1 year follow Up results of “ARTIM HF TRIAL” (angiotensin receptor neprilysin inhibitor effect on TEI index & left ventricular mass in heart failure)

BACKGROUND: Sacubitril/Valsartan (ARNI) has now class 1 recommendation for treatment of heart failure with reduced ejection fraction (HFrEF). It has been shown to reduce cardiovascular morbidity & mortality in Heart failure with reduced ejection fraction (HFrEF) and significant improvement in al...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Indian Heart J
Main Authors: Gokhroo, Rajendra Kumar, Anushri, Kaul, Tarik, M.T., Kailash, C., Rajesh, N., Ashish, K., Manish, G., Subhash, C.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8065347/
https://ncbi.nlm.nih.gov/pubmed/33865519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ihj.2021.01.010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados